Tilikum Therapeutics
PrivateLast Round
Seed
Jun 1, 2023
Company Overview
Tilikum Therapeutics is a biotechnology company developing a new class of small-molecule PARP1-selective inhibitors to treat treatment-resistant solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tilikum Therapeutics Comparables
Compare Tilikum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acerand Therapeutics | 87% | |
| Eikon Therapeutics | 76% | |
| IMPACT Therapeutics | 73% |
Tilikum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2023 |
Tilikum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delin Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2023
Seed round led by Delin Ventures.
Tilikum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tilikum Therapeutics's valuation, stock price, and market status.
Is Tilikum Therapeutics a public or private company?
Tilikum Therapeutics is a private company.
What is the current stock price of Tilikum Therapeutics?
Tilikum Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tilikum Therapeutics worth (valuation)?
Valuation information for Tilikum Therapeutics is not publicly available.
Can I buy Tilikum Therapeutics stock?
Tilikum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tilikum Therapeutics's last funding round?
Tilikum Therapeutics's most recent funding round was Seed on June 1, 2023.
Who are the main investors in Tilikum Therapeutics?
Key investors in Tilikum Therapeutics include Delin Ventures.
Will Tilikum Therapeutics IPO soon?
No public IPO plans have been announced for Tilikum Therapeutics.
How can I track Tilikum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tilikum Therapeutics's secondary market activity and sign up for updates.